Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 20/20 | 0.91 |
| ▸ | JAK2 | O60674 | 2/20 | 0.66 |
| ▸ | AURKA | O14965 | 1/20 | 0.58 |
| ▸ | PRKCA | P17252 | 1/20 | 0.58 |
| ▸ | KDR | P35968 | 1/20 | 0.58 |
| ▸ | JAK3 | P52333 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12385202 | 0.96 | JAK1 (1.00) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2296459 | 0.93 | JAK1 (1.00) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2296140 | 0.93 | JAK1 (1.00) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL13823506 | 0.88 | JAK1 (0.72) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2274309 | 0.83 | JAK1 (0.78) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL9952380 | 0.82 | JAK1 (0.74) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL9952376 | 0.82 | JAK1 (0.74) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2280228 | 0.81 | JAK1 (0.69) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2275676 | 0.81 | JAK1 (1.00) | JAK1JAK2AURKAPRKCAKDR | |
| SCHEMBL2275679 | 0.81 | JAK1 (1.00) | JAK1JAK2AURKAPRKCAKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |